Article Quality of End-of-Life Care for People with Advanced Non-Small Cell Lung Cancer in Ontario: A Population-Based Study Catherine L. Goldie 1,* , Paul Nguyen 2, Andrew G. Robinson 3,4,5, Craig E. Goldie 3,5 , Colleen E. Kircher 1 and Timothy P. Hanna 2,3,4,5 1 School of Nursing, Queen’s University, Kingston, ON K7L 3N6, Canada;
[email protected] 2 ICES Queen’s, Queen’s University, Kingston, ON K7L 3L4, Canada;
[email protected] (P.N.);
[email protected] (T.P.H.) 3 School of Medicine, Queen’s University, Kingston, ON K7L 3N6, Canada;
[email protected] (A.G.R.);
[email protected] (C.E.G.) 4 Division of Cancer Care and Epidemiology, Queen’s Cancer Research Institute, Kingston, ON K7L 3N6, Canada 5 Department of Oncology, Queen’s University, Kingston, ON K7L 5P9, Canada * Correspondence:
[email protected]; Tel.: +1-613-533-6000 (ext. 78229) Abstract: Ensuring high quality end of life (EOL) care is necessary for people with advanced non-small-cell lung cancer (NSCLC), given its high incidence, mortality and symptom burden. Aggressive EOL care can adversely affect the quality of life of NSCLC patients without providing meaningful oncologic benefit. Objectives: (1) To describe EOL health services quality indicators and timing of palliative care consultation provided to patients dying of NSCLC. (2) To examine associations between aggressive and supportive care and patient, disease and treatment charac- teristics. Methods: This retrospective population-based cohort study describes those who died of NSCLC in Ontario, Canada from 2009–2017.